Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nancy Van Prooyen
Observed name:
Prooyen, N Van
Institution:
Bristol-Myers Squibb (United States)
Observed institutions:
National Institutes of Health,
Howard Hughes Medical Institute,
Johns Hopkins University,
University of California, San Francisco,
Bristol-Myers Squibb (United States),
National Cancer Institute
show all 6
OpenAlex ID:
A5014192044
Works
10
Awards
1
Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission
2010
·
Nancy Van Prooyen
, Heather Gold
, et al.
·
Proceedings of the National Academy of Sciences
·
206
Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins
2010
·
Nancy Van Prooyen
, Vibeke Andresen
, et al.
·
Molecular Aspects of Medicine
·
55
Interaction of Bap31 and MHC Class I Molecules and Their Traffic Out of the Endoplasmic Reticulum
2009
·
Fumiyoshi Abe
, Nancy Van Prooyen
, et al.
·
The Journal of Immunology
·
51
CD103+ Conventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans
2016
·
Nancy Van Prooyen
, C. Allen Henderson
, et al.
·
PLoS Pathogens
·
42
PDF
The 3-Hydroxy-Methylglutaryl Coenzyme A LyaseHCL1Is Required for Macrophage Colonization by Human Fungal Pathogen Histoplasma capsulatum
2012
·
Dervla T. Isaac
, Alison Coady
, et al.
·
Infection and Immunity
·
39
PDF
The transcription factor CHOP, an effector of the integrated stress response, is required for host sensitivity to the fungal intracellular pathogen Histoplasma capsulatum
2017
·
Bevin C. English
, Nancy Van Prooyen
, et al.
·
PLoS Pathogens
·
35
PDF
Role of dimerization and palmitoylation on the function of HTLV-1 p12 and p8
2011
·
Dustin Edwards
, Risaku Fukumoto
, et al.
·
Retrovirology
·
2
PDF
Randomized Controlled Study of Bacteriophages in Acne Reveals Efficacy and Novel Mechanism for Promoting Long-Term Skin Health
2026
·
Nancy Van Prooyen
, Maria Cho
, et al.
·
Journal of Drugs in Dermatology
·
1
560 First-in-human phase 1/2 study (CA052-002) evaluating the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of imzokitug (BMS-986340), an anti-CCR8 monoclonal antibody
2026
·
Matteo Simonelli
, Yasutoshi Kuboki
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
10
Citation count:
431
H-index:
6
I10-index:
6
Year
Topic
Type